Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose versus oral iron for perioperative anemia in colorectal cancer surgery
NL-OMON50394Phase 4Active, not recruiting
- Sponsor
- Chirurgie
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose and ferrous fumarate in iron deficiency anemia (IDA) (2 arms), sponsored by Chirurgie. Started Oct 2014; status: active, not recruiting.
02
Drugs
ferric carboxymaltoseferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON50394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50394.